Leniency: The CFI reduces the fines in the Daiichi Pharmaceutical and BASF cases

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. – CFI, 15 March 2006, Daiichi Pharmaceutical v. Commission, Case T-26/02 – CFI, 15 March 2006, BASF v. Commission, Case T-15/02 1. BASF Leader or instigator, are the two concepts equivalent? This is, briefly summarised, one of the many questions which the CFI had to answer in the context of the appeal brought by BASF against the Commission's decision in the Vitamins case of 21 November 2001. As is well known, the Commission has identified more than a dozen separate infringements in the cases, all relating to different vitamin product markets. BASF contested, in particular with regard to the treatment of other cartel members, the characterisation of BASF